BPG is committed to discovery and dissemination of knowledge
Topic Highlight
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 28, 2014; 20(32): 11054-11061
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11054
Figure 1
Figure 1 Speculative illustration. Speculative illustration of expected hepatitis C virus (HCV)-RNA load and transaminase flare during and after rituximab cyclophosphamide, hydroxydaunorubicin, vincristine, prednisolone (R-CHOP) immmunochemotherapy for a diffuse large B-cell lymphoma ideal patient (not cirrhotic, no other risk factors) experiencing transient toxicity. Curves and histograms reflect the average behavior of patients reported so far in the literature.


Write to the Help Desk